Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2012

View Archived Issues

Novel TTK inhibitors patented by Bayer Schering Pharma

Array BioPharma synthesizes novel kinase inhibitors

Allergan patents new CCR2 receptor antagonists

Novel protein kinase inhibitors disclosed by Roche

German researchers present new GPR119 receptor agonists

Abbott designs new potential hepatitis therapies

AbOs-targeted antibodies show potential in Alzheimer's disease model

Abbott halts development of two clinical-stage candidate drugs for Alzheimer's disease

New AHA/ACC guideline update includes ticagrelor

New candidate biomarker for prostate cancer discovered

Eisai and Verastem enter research collaboration

AstraZeneca plans to evaluate ticagrelor in patients with PAD

Oncolytic virus research collaboration begins for bladder cancer

Phase II results presented on insulin analogue for diabetes

German authorities approve SkyePharma's asthma product

FDA advisory committee to discuss NDAs for Novo Nordisk insulin products

FDA approves VIVUS drug for weight management

U.S. scientists develop new model of early-onset Alzheimer's disease

Orphan medicinal product designation granted for levoglutamide

Janssen seeks U.S. and E.U. approval for Simponi

Grifols to conduct safety study of inhaled alpha1-proteinase inhibitor

Medgenics commences Israeli study of Epodure Biopumps

Isotechnika receives further funding from Canadian government

Nymox provides update on pivotal U.S. phase III trials in BPH

Antisense Therapeutics executes agreement for ATL-1102

FDA grants orphan drug status to antibody-drug conjugate in mesothelioma

Soligenix receives grant for acute radiation syndrome therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...